Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection
NCT: NCT07796451 · NOT_YET_RECRUITING
Brief Summary
This randomized, double-blind, sham-controlled trial will evaluate whether perioperative low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve early postoperative in-hospital sleep quality in adults undergoing elective thoracoscopic lung resection for primary lung cancer. A total of 220 participants with preoperative sleep impairment will be randomly assigned in a 1:1 ratio to active rTMS or matched sham stimulation. Active rTMS will target the left dorsolateral prefrontal cortex. Five stimulation sessions will be delivered within a 7-day perioperative window: two sessions before surgery, one session after extubation when the participant is clinically stable, and one session on each of postoperative days 1 and 2. The primary outcome is sleep quality measured using the Richards-Campbell Sleep Questionnaire during the first three postoperative inpatient nights. The study will also evaluate wearable-device sleep measures, postoperative pain and analgesic use, recovery, safety, feasibility, and changes in brain activity measured by 64-channel electroencephalography.
Frequently Asked Questions
What is Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection?
Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection is a clinical trial registered under NCT07796451. Current status: NOT_YET_RECRUITING.
What is the status of NCT07796451?
The current status of NCT07796451 (Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection) is: NOT_YET_RECRUITING.
When did Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection start?
Perioperative Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection started on 2026-08-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.